Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age

Recruiting

Early Phase 1

Metformin vs. Birth Control PillRelative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age

Sponsor:

University of Virginia

Code:

NCT03905941

Conditions

Polycystic Ovary Syndrome

Eligibility Criteria

Sex: Female

Age: 40 - 49

Healthy Volunteers: Accepted

Interventions

Metformin

Oral combined hormonal contraceptives

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by University of Virginia on 2023-11-03.